1
|
Ma YX, Zhang H, Li XH and Liu YH:
miR-30e-5p inhibits proliferation and metastasis of nasopharyngeal
carcinoma cells by targeting USP22. Eur Rev Med Pharmacol Sci.
22:6342–6349. 2018.PubMed/NCBI
|
2
|
Lao TD, Nguyen TV, Nguyen DH, Nguyen MT,
Nguyen CH and Le THA: miR-141 is up-regulated in biopsies from
Vietnamese patients with nasopharyngeal carcinoma. Braz Oral Res.
32:e1262018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Chua MLK, Wee JTS, Hui EP and Chan ATC:
Nasopharyngeal carcinoma. Lancet. 387:1012–1024. 2016. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kamran SC, Riaz N and Lee N:
Nasopharyngeal carcinoma. Surg Oncol Clin N Am. 24:547–561. 2015.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Lee AW, Ma BB, Ng WT and Chan AT:
Management of nasopharyngeal carcinoma: Current practice and future
perspective. J Clin Oncol. 33:3356–3364. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Lin CH, Chiang MC and Chen YJ:
MicroRNA-328 inhibits migration and epithelial-mesenchymal
transition by targeting CD44 in nasopharyngeal carcinoma cells.
OncoTargets Ther. 11:2375–2385. 2018. View Article : Google Scholar
|
7
|
Zhu HM, Jiang XS, Li HZ, Qian LX, Du MY,
Lu ZW, Wu J, Tian XK, Fei Q, He X, et al: miR-184 inhibits tumor
invasion, migration and metastasis in nasopharyngeal carcinoma by
targeting Notch2. Cell Physiol Biochem. 49:1564–1576. 2018.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhu X, Li W, Zhang R and Liu Y:
MicroRNA-342 inhibits cell proliferation and invasion in
nasopharyngeal carcinoma by directly targeting ZEB1. Oncol Lett.
16:1298–1304. 2018.PubMed/NCBI
|
9
|
Feng X, Lv W, Wang S and He Q: miR-495
enhances the efficacy of radiotherapy by targeting GRP78 to
regulate EMT in nasopharyngeal carcinoma cells. Oncol Rep.
40:1223–1232. 2018.PubMed/NCBI
|
10
|
Zhang Y, Xu J, Zhang S, An J, Zhang J,
Huang J and Jin Y: HOXA-AS2 promotes proliferation and induces
epithelial-mesenchymal transition via the miR-520c-3p/GPC3 axis in
hepatocellular carcinoma. Cell Physiol Biochem. 50:2124–2138. 2018.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Xia F, Chen Y, Jiang B, Du X, Peng Y, Wang
W, Huang W, Feng T and Li X: Long noncoding RNA HOXA-AS2 promotes
papillary thyroid cancer progression by regulating
miR-520c-3p/S100A4 rathway. Cell Physiol Biochem. 50:1659–1672.
2018. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang Y, Zhang R, Cheng G, Xu R and Han X:
Long non-coding RNA HOXA-AS2 promotes migration and invasion by
acting as a ceRNA of miR-520c-3p in osteosarcoma cells. Cell Cycle.
17:1637–1648. 2018. View Article : Google Scholar : PubMed/NCBI
|
13
|
Tang CP, Zhou HJ, Qin J, Luo Y and Zhang
T: MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to
suppress the invasion and migration of breast cancer. Oncol Rep.
38:3144–3152. 2017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Stenmark H: Rab GTPases as coordinators of
vesicle traffic. Nat Rev Mol Cell Biol. 10:513–525. 2009.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhang Y, Zhao FJ, Chen LL, Wang LQ, Nephew
KP, Wu YL and Zhang S: miR-373 targeting of the Rab22a oncogene
suppresses tumor invasion and metastasis in ovarian cancer.
Oncotarget. 5:12291–12303. 2014.PubMed/NCBI
|
16
|
Zhou Y, Wu B, Li JH, Nan G, Jiang JL and
Chen ZN: Rab22a enhances CD147 recycling and is required for lung
cancer cell migration and invasion. Exp Cell Res. 357:9–16. 2017.
View Article : Google Scholar : PubMed/NCBI
|
17
|
He H, Dai F, Yu L, She X, Zhao Y, Jiang J,
Chen X and Zhao S: Identification and characterization of nine
novel human small GTPases showing variable expressions in liver
cancer tissues. Gene Expr. 10:231–242. 2002. View Article : Google Scholar : PubMed/NCBI
|
18
|
Yin Y, Zhang B, Wang W, Fei B, Quan C,
Zhang J, Song M, Bian Z, Wang Q, Ni S, et al: miR-204-5p inhibits
proliferation and invasion and enhances chemotherapeutic
sensitivity of colorectal cancer cells by downregulating RAB22A.
Clin Cancer Res. 20:6187–6199. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Xia Z, Liu F, Zhang J and Liu L: Decreased
expression of miRNA-204-5p contributes to glioma progression and
promotes glioma cell growth, migration and invasion. PLoS One.
10:e01323992015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Sun L, He M, Xu N, Xu DH, Ben-David Y,
Yang ZY and Li YJ: Regulation of RAB22A by mir-193b inhibits breast
cancer growth and metastasis mediated by exosomes. Int J Oncol.
53:2705–2714. 2018.PubMed/NCBI
|
21
|
Lu J, Liu QH, Wang F, Tan JJ, Deng YQ,
Peng XH, Liu X, Zhang B, Xu X and Li XP: Exosomal miR-9 inhibits
angiogenesis by targeting MDK and regulating PDK/AKT pathway in
nasopharyngeal carcinoma. J Exp Clin Cancer Res. 37:1472018.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S,
Long X, Jiang Q, Song Y, Cheng C, et al: Tumor suppressor PDCD4
modulates miR-184-mediated direct suppression of C-MYC and BCL2
blocking cell growth and survival in nasopharyngeal carcinoma. Cell
Death Dis. 4:e8722013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Yi M, Cai J, Li J, Chen S, Zeng Z, Peng Q,
Ban Y, Zhou Y, Li X, Xiong W, et al: Rediscovery of NF-κB signaling
in nasopharyngeal carcinoma: How genetic defects of NF-κB pathway
interplay with EBV in driving oncogenesis? J Cell Physiol.
233:5537–5549. 2018. View Article : Google Scholar : PubMed/NCBI
|
24
|
Ma J, Xuan SH, Li Y, Zhang ZP and Li XH:
Role of the TGFβ/PDCD4/AP-1 signaling pathway in nasopharyngeal
carcinoma and its relationship to prognosis. Cell Physiol Biochem.
43:1392–1401. 2017. View Article : Google Scholar : PubMed/NCBI
|
25
|
Tutar Y: miRNA and cancer; computational
and experimental approaches. Curr Pharm Biotechnol. 15:4292014.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Berindan-Neagoe I, Monroig PC, Pasculli B
and Calin GA: MicroRNAome genome: A treasure for cancer diagnosis
and therapy. CA Cancer J Clin. 64:311–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
27
|
Fendler A, Stephan C, Yousef GM and Jung
K: MicroRNAs as regulators of signal transduction in urological
tumors. Clin Chem. 57:954–968. 2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
Eulalio A, Huntzinger E and Izaurralde E:
Getting to the root of miRNA-mediated gene silencing. Cell.
132:9–14. 2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Su F, Chen Y, Zhu S, Li F, Zhao S, Wu L,
Chen X and Su J: RAB22A overexpression promotes the tumor growth of
melanoma. Oncotarget. 7:71744–71753. 2016. View Article : Google Scholar : PubMed/NCBI
|
30
|
Xiong F, Liu K, Zhang F, Sha K, Wang X,
Guo X and Huang N: miR-204 inhibits the proliferation and invasion
of renal cell carcinoma by inhibiting RAB22A expression. Oncol Rep.
35:3000–3008. 2016. View Article : Google Scholar : PubMed/NCBI
|